![](/web/20061211032854im_/http://www.phac-aspc.gc.ca/gfx_temp/spacer.gif) |
|
![](/web/20061211032854im_/http://www.phac-aspc.gc.ca/gfx_temp/spacer.gif) |
![](/web/20061211032854im_/http://www.phac-aspc.gc.ca/gfx_temp/18px.gif) |
HIV/AIDS - Epi Updates - 2005 May 2005 PDF
Version * (763
KB) Mission To promote and protect the health of Canadians through
leadership, partnership, innovation and action in public health.
Public
Health Agency of Canada This document is available:
By mail |
Surveillance and Risk Assessment Division
Centre for Infectious Disease Prevention and Control
Public Health Agency of Canada
Tunney’s Pasture
Address locator: 0602B
Ottawa, Ontario, Canada, K1A 0K9 |
Or from |
HIV/AIDS Clearinghouse
Canadian Public Health Association
1565 Carling Avenue, Suite 400
Ottawa, Ontario, Canada, K1Z 8R1
Tel.: (613) 725-3434, Fax: (613) 725-1205 |
By internet |
HIV/AIDS Epi Updates can be assessed electronically in either official
language via the Internet at www.phac-aspc.gc.ca. |
© Her
Majesty the Queen in Right of Canada, represented by the Minister
of Health (2005)
Cat. H121-5/2005E ISBN 0-662-40424-6
(On-line) Cat. H121-5/2005E-PDF
ISBN 0-662-40425-4 Acknowledgements National level HIV and AIDS surveillance is possible as a result of all
provinces and territories
participating in, and setting directions for, HIV and AIDS surveillance.
Accordingly, the Centre
for Infectious Disease Prevention and Control acknowledges the provincial/territorial
HIV/AIDS
coordinators, public health units, laboratories, health care providers and
reporting physicians
for providing the non-nominal confidential data that enable this report
to be published. Without
their close collaboration and participation in HIV and AIDS surveillance,
the publication of this
report would not have been possible. The Centre for Infectious Disease Prevention
and Control
also acknowledges the contributions of many researchers, community members,
and nongovernmental
organizations, including the Canadian AIDS Society, for their valuable inputs
and comments during the preparation of this report.
N.B. This document must be cited as the source of any information
extracted and used from it.
Suggested citation: Public Health Agency of Canada. HIV/AIDS
Epi Updates,
May 2005, Surveillance and Risk Assessment Division, Centre for Infectious
Disease Prevention and Control, Public Health Agency of Canada, 2005 |
Information to the readers of
HIV/AIDS Epi Updates The Surveillance and Risk Assessment Division of the
Centre for Infectious Disease Prevention
and Control, Public Health Agency of Canada, is pleased to provide you
with the May 2005
publication of HIV/AIDS Epi Updates. The Centre conducts national surveillance and research on the epidemiology
and laboratory
science related to HIV/AIDS. As part of this mandate, HIV/AIDS Epi Updates
are compiled on
an annual basis to summarize recent trends and developments related
to the HIV epidemic in
Canada. All Epi Updates are available at the address noted above and also
at our website: The HIV/AIDS Epi Updates are complementary to other
Centre materials,
which are also available at the website.
Sincerely, ![Chris Archibald](/web/20061211032854im_/http://www.phac-aspc.gc.ca/publicat/epiu-aepi/epi-05/gfx/archibald.gif)
Chris Archibald MDCM, MHSc, FRCPC
Director
Centre for Infectious Disease Prevention and Control
Surveillance and Risk Assessment Division |
Tel.: (613) 954-5169 |
Fax: (613) 946-8695 |
Division personnel who contribute to the production of the Epi Updates
are noted
below:
Director |
Chris Archibald, MDCM, MHSc, FRCPC |
Executive Assistant |
Moheenee Soondrum |
HIV/AIDS Epidemiology Section |
|
Contractor |
Yogesh Choudhri, MD, MPH |
Surveillance Officer |
Stephen Cule, BSc |
Contractor |
Tony Bove-Dallas |
HIV/AIDS Surveillance Section |
Manager |
Jennifer Geduld, MHSc, BSc |
Senior Research Analyst |
Jennifer Pennock, MSc, BSc |
Research Analyst |
Chris Sheardown, BA |
Surveillance Officer |
Bruce Tudin, MA, BES |
Surveillance Analyst |
Caroline Chevalier, BSc |
Surveillance Analyst |
Stéphane Racette |
HIV Drug Resistance and Field Surveillance Section |
Senior Field Surveillance Officer |
Tig Shafto, PhD |
Senior Epidemiologist |
Gayatri Jayaraman, PhD, MPH |
Research Analyst |
Neil Goedhuis, BSc |
Field Surveillance Officer |
Elsie Wong, MBA, BSN |
Field Surveillance Officer |
Michelyn Wood, MS, BS |
Field Surveillance Officer |
Sonia Harmen, MAppS, BSc |
Field Surveillance Officer |
Jane Njihia, MHSc, BSc, RN |
Field Surveillance Officer |
Tracey MacDonald, BN, MN, CMHN |
Contractor |
Sabrina Plitt, PhD |
Table of Contents
1 |
National HIV Prevalence and Incidence Estimates for 2002 |
2 |
Prevalent HIV Infections in Canada: 30% May Not Be Diagnosed |
3 |
HIV Testing and Infection Reporting in Canada |
4 |
HIV and AIDS among Youth in Canada |
5 |
HIV and AIDS among Women in Canada |
6 |
HIV/AIDS among Older Canadians |
7 |
Perinatal Transmission of HIV |
8 |
Ethnicity Reporting for AIDS and HIV in Canada: Aboriginal and
Black Communities Demand Attention |
9 |
HIV/AIDS among Aboriginal Peoples in Canada: A Continuing Concern |
10 |
HIV Infections among MSM in Canada |
11 |
HIV/AIDS among Injecting Drug Users in Canada |
12 |
Risk Behaviours among Injecting Drug Users in Canada |
13 |
Oral Sex and the Risk of HIV Transmission |
14 |
HIV-1 Strain Surveillance in Canada |
15 |
Primary HIV Anti-retroviral Drug Resistance in Canada |
16 |
Nonoxynol-9 and the Risk of HIV Transmission |
Glossary |
|